S008 Update in General Dermatology
DESCRIPTION
This session will review the current state of knowledge, evaluation, and treatment of hidradenitis suppurativa, use of JAK inhibitors in inflammatory skin disease, cancer-directed immunotherapy reactions, morphea/sclerderma, lupus, dermatomyositis, and urticaria.
LEARNING OBJECTIVES
Evaluate the latest advances in pathophysiology for hidradenitis suppurativa, cancer-associated immunotherapy reactions, morphea/scleroderma, cutaneous lupus erythematosus and dermatomyositis, and urticaria.
Determine new approaches to use of JAK inhibitors in inflammatory skin diseaes.
Review current treatments and new developments for hidradenitis suppurativa, cancer-associated immunotherapy reactions, morphea/scleroderma, cutaneous lupus erythematosus and dermatomyositis, and urticaria.
SCHEDULE
9:00 AM
Current approaches to Hidradenitis Suppuritiva
Amit Garg, MD, FAAD
9:30 AM
Inflammatory skin disease and JAK inhibitors
Brett King, MD, PhD, FAAD
10:00 AM
Managing cancer-directed immunotherapy reactions
10:30 AM
Update on Morphea/scleroderma
Nicole Fett, MD, FAAD
11:00 AM
Evaluation and management of urticaria
Gil Yosipovitch, MD
11:30 AM
Update in Cutaneous lupus and Dermatomyositis
Victoria P. Werth, MD, FAAD
DIRECTOR
Victoria P. Werth, MD, FAAD
SPEAKERS
Nicole Fett, MD, FAAD
Amit Garg, MD, FAAD
Brett King, MD, PhD, FAAD
Nicole LeBoeuf, MD, FAAD
Gil Yosipovitch, MD
DISCLOSURES
Nicole Fett, MD, FAAD
Astra Zeneca – Investigator(Fees); UpToDate – Other(Honoraria);
Amit Garg, MD, FAAD
AbbVie – Advisory Board(Honoraria); Almirall – Consultant (1099 relationship)(Fees); Incyte Corporation – Advisory Board(Honoraria); Insmed Incorporated – Consultant (1099 relationship)(Honoraria); Novartis – Consultant(Honoraria); Pfizer Inc. – Investigator(Grants/Research Funding); Sanofi – Data Safety Monitoring Board(Fees); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Fees); UCB – Consultant(Honoraria); Zura Bio – Consultant (1099 relationship)(Fees);
Brett King, MD, PhD, FAAD
AbbVie – Advisory Board(Honoraria), Speaker(Honoraria); Amgen – Consultant (1099 relationship)(Fees); Apogee Therapeutics – Consultant (1099 relationship)(Fees); Aquestive Therapeutics – Consultant (1099 relationship)(Fees); BiologicsMD, Inc. – Consultant(Stock Options); Bristol-Myers Squibb – Advisory Board(Honoraria), Consultant(Fees); Eli Lilly and Company – Consultant(Fees), Investigator(Fees), Speaker(Honoraria); Galderma – Advisory Board(Honoraria); GlaxoSmithKline Immunology – Consultant (1099 relationship)(Fees); Incyte Corporation – Advisory Board(Honoraria), Consultant(Fees), Data Safety Monitoring Board(Fees); Leo Pharma – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Fees), Advisory Board(Honoraria), Consultant(Fees), Investigator(Fees), Speaker(Honoraria); Q32 Bio Inc. – Consultant (1099 relationship)(Fees); Regeneron – Advisory Board(Honoraria), Speaker(Honoraria); Sanofi – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Sanofi Genzyme – Speaker(Honoraria); Soterios Pharma – Consultant (1099 relationship)(Fees); Sun Pharmaceutical Industries Ltd. – Consultant(Fees), Investigator(Fees); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); TWi Biotechnology, Inc. – Consultant(Fees);
Nicole LeBoeuf, MD, FAAD
Bayer – Speaker/Faculty Education(Honoraria); Fortress Biotech, Inc. – Consultant(Honoraria); Sanofi – Consultant(Honoraria); Seattle Genetics – Consultant(Honoraria); Silverback Therapeutics – Consultant(Honoraria); SynOx Therapeutics – Consultant(Honoraria);
Victoria P. Werth, MD, FAAD
AbbVie – Consultant (1099 relationship)(Fees); Amgen – Investigator(Grants/Research Funding); AnaptysBio – Consultant(Honoraria); Architect Therapeutics – Consultant (1099 relationship)(Fees); argenx – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Astra Zeneca – Investigator(Grants/Research Funding); AstraZeneca – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Data Safety Monitoring Board(Honoraria); Atticus Pharma, Inc. – Consultant (1099 relationship)(Honoraria); Biogen – Consultant(Honoraria), Investigator(Grants/Research Funding); BMS – Consultant(Honoraria); Boehringer Ingelheim – Consultant (1099 relationship)(Honoraria); Cabaletta Bio – Consultant (1099 relationship)(Honoraria); Celexor Bio – Consultant (1099 relationship)(Fees); Corbus Pharmaceuticals – Investigator(Grants/Research Funding); CSL Behring – Consultant(Honoraria), Investigator(Grants/Research Funding); Cugene – Consultant(Honoraria); Duality Bio – Consultant (1099 relationship)(Fees); EMD Serono – Consultant(Honoraria); Everest Clinical Research – Consultant (1099 relationship)(Honoraria); Exo Therapeutics – Consultant (1099 relationship)(Honoraria); Gilead Sciences – Consultant(Honoraria), Investigator(Grants/Research Funding); GlaxoSmithKline – Consultant(Honoraria); Glycoera – Investigator(Grants/Research Funding); Horizon Pharma, Inc. – Investigator(Grants/Research Funding); Immunovant – Consultant (1099 relationship)(Honoraria); Janssen Pharmaceuticals, Inc – Consultant(Honoraria), Investigator(Grants/Research Funding); Kyowa Hakko Kirin Pharma, Inc. – Consultant(Honoraria); Lilly ICOS LLC – Consultant(Honoraria); Lumanity – Consultant (1099 relationship)(Honoraria); Lupus Foundation of America – Consultant(Honoraria); Merck & Co., Inc – Consultant(Honoraria); Novartis – Advisory Board(Honoraria); Nuvig Therapeutics – Consultant (1099 relationship)(Honoraria); Odyssey Therapeutics – Consultant (1099 relationship)(Fees); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Priovant Therapeutics – Investigator(Grants/Research Funding); Regeneron Pharmaceuticals, Inc. – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); ROME Therapeutics – Consultant(Honoraria); Sanofi Aventis – Consultant(Honoraria); UCB – Consultant(Honoraria); Ventus Therapeutics – Investigator(Grants/Research Funding); Viela Bio – Consultant(Honoraria), Investigator(Grants/Research Funding); Vindico Medical Education – Speaker/Faculty Education(Honoraria);
Gil Yosipovitch, MD
AbbVie – Advisory Board(Honoraria); Arcutis, Inc. – Advisory Board(Honoraria); Cara Therapeutics – Advisory Board(Honoraria); CeraVe – Advisory Board(Honoraria); Eli Lilly – Investigator(Fees), Investigator(Grants/Research Funding); Eli Lilly and Company – Advisory Board(Honoraria); escient – Investigator(Fees), Investigator(Grants/Research Funding); Galderma – Advisory Board(Honoraria); Galderma Laboratories, L.P. – Consultant(Honoraria), Investigator(Fees), Investigator(Grants/Research Funding); GSK – Advisory Board(Honoraria); Kamari Pharma – Consultant(Fees); Kiniksa Pharmaceuticals, Ltd. – Investigator(Grants/Research Funding); Maruho Co., Ltd – Speaker/Faculty Education(Fees); Novartis – Consultant(Honoraria), Investigator(Fees), Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Pierre Fabre – Consultant(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria), Investigator(Fees), Investigator(Grants/Research Funding); Vifor Pharma – Consultant(Fees);